Search results for: 'magnesium sulfate ot'

Magnesium sulphate heptahydrate (EP 7.0) is a pharmaceutical-grade compound widely used in medical and healthcare applications. It is commonly administered as a laxative for the short-term relief of constipation and as an electrolyte replenisher to treat magnesium deficiency. In clinical settings, it is also used intravenously to manage conditions such as eclampsia, pre-eclampsia, and certain cardiac arrhythmias under strict medical supervision. Additionally, it serves as an excipient in pharmaceutical formulations and as a soaking agent for external use to relieve muscle pain, inflammation, and swelling, ensuring safety and quality in compliance with European Pharmacopoeia standards.

Magnesium sulphate heptahydrate (BP 2007, 2008, 2009) is widely used in pharmaceutical and medical applications. It is commonly employed as an osmotic laxative for the relief of constipation and for bowel evacuation prior to diagnostic or surgical procedures. In injectable form, it is used to treat hypomagnesaemia, eclampsia, and certain cardiac arrhythmias. It also serves as an electrolyte replenisher and anticonvulsant. In addition, magnesium sulphate heptahydrate is used in pharmaceutical formulations as a stabilizer and processing aid, complying with British Pharmacopoeia quality standards.

Magnesium sulphate anhydrate, complying with BP 2007/2010 standards, is widely used in pharmaceutical, medical, and laboratory applications. In medicine, it serves as a source of magnesium for correcting hypomagnesaemia and is used in the formulation of oral and parenteral preparations. It also functions as an excipient, drying agent, and stabilizer in pharmaceutical manufacturing due to its hygroscopic properties. In laboratories, it is commonly used as a desiccant for drying organic solvents. Additionally, it is applied in chemical synthesis and quality-controlled processes where high purity and pharmacopeial compliance are required.